![John Byon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Byon
Chief Tech/Sci/R&D Officer at
IMUGENE LIMITED
Net worth: 5 407 $ as of 31/05/2026
Profile
John Byon currently works at Imugene Ltd., as Chief Medical Officer from 2025.
Dr. Byon also formerly worked at Fate Therapeutics, Inc., as Vice President-Clinical Development.
Dr. Byon received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from Tulane University (Louisiana).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMUGENE LTD 0.02% | 30/06/2025 | 65,348 ( 0.02% ) | 5 407 $ | 31/05/2026 |
John Byon active positions
| Companies | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 01/09/2023 |
Former positions of John Byon
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of John Byon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- John Byon
